Lumexa Imaging (LMRI) awards 12,414 RSUs to Principal Accounting Officer

Rhea-AI Filing Summary

Lumexa Imaging Holdings, Inc. reported that its Principal Accounting Officer, Walker James Edward Jr., acquired 12,414 shares of common stock in the form of restricted stock units. The grant carried a price of $0.0000 per share, indicating it was an equity award rather than an open-market purchase.

Each RSU represents the contingent right to receive one share of Lumexa common stock. The RSUs vest in three substantially equal annual installments on each of the first three anniversaries of the grant date, conditioned on Mr. Walker’s continued service with the company. Following this award, his directly owned common stock and RSUs total 17,346 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walker James Edward Jr.

(Last) (First) (Middle)

4200 SIX FORKS ROAD

SUITE 1000

(Street)

RALEIGH NC 27609

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lumexa Imaging Holdings, Inc. [ LMRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		A		12,414(1)	A	$0	17,346	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

	/s/ Julie Szeker, attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lumexa Imaging (LMRI) disclose in this Form 4?

Lumexa Imaging disclosed that Principal Accounting Officer Walker James Edward Jr. received an equity award of 12,414 restricted stock units. These RSUs represent a contingent right to receive common shares and are part of his compensation rather than an open-market stock purchase.

How many Lumexa Imaging (LMRI) shares did the insider acquire and at what price?

The insider was granted 12,414 restricted stock units of Lumexa Imaging common stock at a stated price of $0.0000 per share. This indicates a compensatory equity grant, not a cash purchase, aligning the officer’s incentives with long-term shareholder interests.

How do the new RSUs for Lumexa Imaging (LMRI) vest over time?

The 12,414 RSUs vest annually in three substantially equal installments on each of the first three anniversaries of the grant date. Vesting is subject to the reporting person’s continued service with Lumexa Imaging, encouraging retention over the three-year vesting period.

What is the total Lumexa Imaging (LMRI) ownership reported after the RSU grant?

After the RSU grant, the filing reports that the insider directly holds 17,346 shares of Lumexa Imaging common stock, including the newly awarded restricted stock units. This figure reflects his total direct beneficial ownership immediately following the reported transaction.

Does the Lumexa Imaging (LMRI) Form 4 reflect a market buy or a compensation grant?

The Form 4 reflects a compensation grant, not a market buy. The 12,414 units were reported under code “A” for grant or award, at a price of $0.0000 per share, indicating an equity incentive award rather than an open-market stock purchase transaction.

Who is the insider involved in this Lumexa Imaging (LMRI) Form 4 filing?

The insider is Walker James Edward Jr., who serves as Lumexa Imaging’s Principal Accounting Officer. The filing reports his receipt of 12,414 restricted stock units that vest over three years, increasing his total directly held common stock and RSUs to 17,346 shares.